HR 4301
106th Congress
House
Health
Commerce
Consumer education
Drug adulteration
Drug industry
Drugs
Drugstores
Government Operations and Politics
Government paperwork
Wholesale trade
To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 24, 2000
Referred to the Subcommittee on Health and Environment.
Apr 13, 2000
Referred to the House Committee on Commerce.
Apr 13, 2000
Sponsor introductory remarks on measure. (CR E586)
Apr 13, 2000
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Amends the Federal Food, Drug, and Cosmetic Act to require the wholesale distributor of certain drugs who is not the manufacturer or an authorized distributor of record for a calendar year (currently, the language "for a calendar year" is not in the Act) of a drug to provide to the recipient of the drug a statement identifying each prior sale, purchase, or trade of such drug.
What's happening now
Referred to the Subcommittee on Health and Environment.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
2
Cite this page
U.S. Congress. (2026). H.R. 4301: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.. 106th Congress. Open America. https://openamerica.io/bill/106-HR-4301/
"H.R. 4301: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-4301/.
H.R. 4301, 106th Cong. (2026), https://openamerica.io/bill/106-HR-4301/.
[H.R. 4301: To amend the Federal Food, Drug, and Cosmetic Act relating to the distribution chain of prescription drugs.](https://openamerica.io/bill/106-HR-4301/)